A committee formally designated to approve, monitor, and review biomedical research involving humans. An IRB has the authority to approve, require modifications in (to secure approval), or disapprove research. This group review serves a role in the protection of the rights, safety and welfare of human research subjects. IRBs often conduct some form of risk-benefit analysis in an attempt to determine whether or not research should be done. Also known as an Independent Ethics Committee or Ethical Review Board.
Glossary
Institutional Review Board (IRB)
03.25.13
-
Promotions & Moves
Akebia Therapeutics Names CMO
Jain to lead clinical development of the company’s HIF pipeline
-
Biologics, Proteins, Vaccines | cGMP Manufacture | Clinical Trial Materials | Collaborations & Alliances | Industry News | Scale-up/Technology Transfer
Merck, Stelis Open First Joint Process Scale-Up Lab in Bengaluru
Combines Stelis' bioprocess development capabilities with Merck's bioprocessing equipment
-
Breaking News | Drug Development | Industry News | Preclinical Outsourcing
Pierre Fabre Buys Igenica Immuno-oncology Assets
Deal reinforces Pierre Fabre’s pipeline in oncology, its primary R&D focus area
-
Biosimilars | Clinical Trials | Drug Discovery | Process Development
Like the Temperature, It Feels Like Deal Activity is Heating Up
A summary of 2016 transactions so farChad Moore, Leerink Partners LLC
-
Clinical Trials | Drug Development
Passage of the 21st Century Cures Act: Modernizing Clinical Trials
ACRO’s John Lewis discusses key areas where greater efficiency in the drug development process can be achievedKristin Brooks, Contract Pharma
